These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10845553)

  • 1. bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.
    Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Cox J; Krammer B; Gatter KC; Harris AL
    Clin Exp Metastasis; 1999; 17(7):545-54. PubMed ID: 10845553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma.
    Kojima H; Shijubo N; Abe S
    Cancer; 2002 Feb; 94(4):1083-93. PubMed ID: 11920479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer.
    Giatromanolaki A; Koukourakis MI; Stathopoulos GP; Kapsoritakis A; Paspatis G; Kakolyris S; Sivridis E; Georgoulias V; Harris AL; Gatter KC
    Oncol Res; 2000; 12(1):33-41. PubMed ID: 11061344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
    Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of angiogenesis in non-small cell lung cancer.
    Giatromanolaki A
    Anticancer Res; 2001; 21(6B):4373-82. PubMed ID: 11908693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer.
    Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Whitehouse RM; Talbot DC; Gatter KC; Harris AL
    Int J Cancer; 1997 Dec; 74(6):565-70. PubMed ID: 9421349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.
    Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Comley M; Whitehouse RM; Talbot DC; Gatter KC; Harris AL
    Br J Cancer; 1997; 75(4):477-81. PubMed ID: 9052396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
    Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
    J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma.
    Li Z; Shimada Y; Uchida S; Maeda M; Kawabe A; Mori A; Itami A; Kano M; Watanabe G; Imamura M
    Int J Oncol; 2000 Sep; 17(3):453-60. PubMed ID: 10938383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
    Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
    Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Sivridis E; O'Byrne K; Gatter KC; Harris AL
    J Pathol; 2000 Oct; 192(2):140-9. PubMed ID: 11004689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
    Bremnes RM; Camps C; Sirera R
    Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.
    Relf M; LeJeune S; Scott PA; Fox S; Smith K; Leek R; Moghaddam A; Whitehouse R; Bicknell R; Harris AL
    Cancer Res; 1997 Mar; 57(5):963-9. PubMed ID: 9041202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways.
    Giatromanolaki A; Koukourakis MI; Sivridis E; O'Byrne K; Cox G; Thorpe PE; Gatter KC; Harris AL
    Clin Cancer Res; 2000 May; 6(5):1917-21. PubMed ID: 10815916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Pastorek J; Wykoff CC; Gatter KC; Harris AL
    Cancer Res; 2001 Nov; 61(21):7992-8. PubMed ID: 11691824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
    Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
    Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.
    Fontanini G; Vignati S; Lucchi M; Mussi A; Calcinai A; Boldrini L; Chiné S; Silvestri V; Angeletti CA; Basolo F; Bevilacqua G
    Br J Cancer; 1997; 75(9):1295-301. PubMed ID: 9155049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.